Onset of symptoms and time to diagnosis of Clostridium difficile -: Associated disease following discharge from an acute care hospital

被引:41
作者
Chang, Heidi T.
Krezolek, Dorota
Johnson, Stuart
Parada, Jorge P.
Evans, Charlesnika T.
Gerding, Dale N.
机构
[1] US Dept Vet Affairs, Vet Affairs Edward Hines Jr Hosp, Midwest Ctr Hlth Serv & Policy Res & Res Serv, Res Serv 151, Hines, IL 60141 USA
[2] Loyola Univ Chicago, Stritch Sch Med, Maywood, IL USA
关键词
D O I
10.1086/519178
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objective. To identify patients with a diagnosis of Clostridium difficile-associated disease (CDAD) in the ambulatory care setting and determine the relationship of symptom onset and diagnosis to prior hospitalization and exposure to antimicrobials. Design. Single-center, retrospective study. Methods. Medical records were reviewed for outpatients and hospitalized patients with a stool assay positive for C. difficile toxin A from January 1998 through March 2005. Patients with recurrent CDAD or residing in an extended-care facility were excluded. CDAD in patients who had been hospitalized in the 100 days prior to diagnosis was considered potentially hospital-associated. Results. Of the 84 patients who met the inclusion criteria, 75 (89%) received a diagnosis 1-60 days after hospital discharge (median, 12 days), and 71 (85%) received a diagnosis within 30 days after discharge. Of the 69 patients whose records contained information regarding time of symptom onset, 62 (90%) developed diarrhea within 30 days of a previous hospital discharge, including 7 patients with symptom onset prior to discharge and 9 with onset on the day of discharge. The median time from symptom onset to diagnosis was 6 days. Of 84 patients, 77 (92%) had received antimicrobials during a prior hospitalization, but 55 (65%) received antimicrobials both as inpatients and as outpatients. Conclusion. If all cases of CDAD diagnosed within 100 days of hospital discharge were assumed to be hospital-associated, 71 (85%) of 84 patients with CDAD were identified within 30 days, and 75 (89%) of 84 were identified by day 60. Continued outpatient antimicrobial exposure confounds determination of whether late-onset cases are community-or hospital-associated.
引用
收藏
页码:926 / 931
页数:6
相关论文
共 13 条
[1]   The distribution of Clostridium difficile in the environment of South Wales [J].
AlSaif, N ;
Brazier, JS .
JOURNAL OF MEDICAL MICROBIOLOGY, 1996, 45 (02) :133-137
[2]   EPIDEMIOLOGY OF COMMUNITY-ACQUIRED CLOSTRIDIUM-DIFFICILE-ASSOCIATED DIARRHEA [J].
HIRSCHHORN, LR ;
TRNKA, Y ;
ONDERDONK, A ;
LEE, MLT ;
PLATT, R .
JOURNAL OF INFECTIOUS DISEASES, 1994, 169 (01) :127-133
[3]   NOSOCOMIAL CLOSTRIDIUM-DIFFICILE COLONIZATION AND DISEASE [J].
JOHNSON, S ;
CLABOTS, CR ;
LINN, FV ;
OLSON, MM ;
PETERSON, LR ;
GERDING, DN .
LANCET, 1990, 336 (8707) :97-100
[4]   Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A. [J].
Kyne, L ;
Warny, M ;
Qamar, A ;
Kelly, CP .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (06) :390-397
[5]   Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile [J].
Kyne, L ;
Hamel, MB ;
Polavaram, R ;
Kelly, CNP .
CLINICAL INFECTIOUS DISEASES, 2002, 34 (03) :346-353
[6]   Antibiotics and Clostridium difficile diarrhea in the ambulatory care setting [J].
Levy, DG ;
Stergachis, A ;
McFarland, LV ;
Van Vorst, K ;
Graham, DJ ;
Johnson, ES ;
Park, BJ ;
Shatin, D ;
Clouse, JC ;
Elmer, GW .
CLINICAL THERAPEUTICS, 2000, 22 (01) :91-102
[7]   Recommendations for surveillance of Clostridium difficile-associated disease [J].
McDonald, L. Clifford ;
Coignard, Bruno ;
Dubberke, Erik ;
Song, Xiaoyan ;
Horan, Teresa ;
Kutty, Preeta K. .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2007, 28 (02) :140-145
[8]   A MOLECULAR CHARACTERIZATION OF CLOSTRIDIUM-DIFFICILE ISOLATES FROM HUMANS, ANIMALS AND THEIR ENVIRONMENTS [J].
ONEILL, G ;
ADAMS, JE ;
BOWMAN, RA ;
RILEY, TV .
EPIDEMIOLOGY AND INFECTION, 1993, 111 (02) :257-264
[9]  
RILEY TV, 1995, CLIN INFECT DIS S2, V20, pS63
[10]   Community-acquired methicillin-resistant Staphylococcus aureus:: A meta-analysis of prevalence and risk factors [J].
Salgado, CD ;
Farr, BM ;
Calfee, DP .
CLINICAL INFECTIOUS DISEASES, 2003, 36 (02) :131-139